Dementia: Assessment and Diagnosis

Key points

  • Dementia: an acquired, progressive decline in cognitive function severe enough to interfere with daily function, in clear consciousness - the umbrella term covering several distinct underlying diseases.
  • Not normal ageing: some slowing of processing speed is expected with age, but functional impairment from cognitive decline is not - it warrants assessment, not reassurance.
  • Screening tools: GPCOG or 6-CIT in primary care for initial screening; MMSE, MoCA or ACE-III for more detailed cognitive assessment, usually in a memory clinic.
  • Reversible causes must be excluded: a standard blood panel (B12, folate, TSH, calcium, glucose, renal/liver function) and, where indicated, imaging, before attributing decline to a primary dementia.
  • Referral: suspected dementia should be referred to a memory clinic or specialist service for formal diagnosis and subtyping, not diagnosed and labelled from a single primary care assessment alone.
  • Diagnosis disclosure: a structured, sensitive process - similar to breaking bad news generally - checking what the patient wants to know and involving them directly, not just family.
  • Post-diagnostic support: signposting, a named coordinator, planning for capacity/finances/driving, and carer support are as much a part of 'management' as any drug.
  • Capacity is decision-specific: a dementia diagnosis does not itself mean a patient lacks capacity for any given decision - each decision must be assessed on its own terms.

Introduction

Dementia is an umbrella term for an acquired, progressive decline in cognitive function - typically involving memory, but also language, executive function, visuospatial skills or personality - occurring in clear consciousness and severe enough to interfere with a person's usual daily activities. It is caused by several distinct underlying diseases (Alzheimer's disease, vascular dementia, Lewy body dementia, frontotemporal dementia and others, each covered separately), but shares a common approach to initial recognition, assessment and diagnosis, which is the focus of this article.1

Around 900,000 people are estimated to be living with dementia in the UK, a figure projected to rise substantially as the population ages, making its recognition and management a core skill across almost every specialty, not just geriatric medicine.

Distinguishing dementia from normal ageing and delirium

Some decline in processing speed and occasional word-finding difficulty is a normal part of ageing and does not, by itself, indicate dementia. What distinguishes dementia is progressive impairment that affects function - difficulty managing finances, medications, or familiar tasks that were previously straightforward.

Delirium - covered in detail in 2 - is acute and fluctuating, in contrast to the gradual, progressive course of dementia, though the two frequently coexist, and an episode of delirium can unmask previously unrecognised or compensated-for dementia. Establishing a clear timeline via collateral history is the key tool for telling them apart.

Presentation

  • Memory: repeating questions, forgetting recent conversations or appointments, misplacing items
  • Language: word-finding difficulty, reduced vocabulary, difficulty following conversation
  • Executive function: difficulty planning, organising, or managing multi-step tasks (finances, medication, cooking)
  • Visuospatial: getting lost in familiar places, difficulty judging distances
  • Behaviour and personality: apathy, disinhibition, irritability, or withdrawal from usual activities and social contact
  • Insight: often reduced, meaning a collateral history from a family member or friend is essential and frequently more revealing than the patient's own account

Cognitive screening tools

Cognitive assessment tools by setting.
ToolSetting / use
GPCOG (General Practitioner Assessment of Cognition)Quick primary care screen, includes both a patient test and an informant interview
6-CIT (6-item Cognitive Impairment Test)Brief primary care screening tool
10-CS / AMT4Very brief bedside screens, AMT4 also forms part of the 4AT delirium screen
MMSE (Mini-Mental State Examination)Widely known 30-point test; licensing restrictions now limit routine free use in the UK, so other tools are increasingly preferred
MoCA (Montreal Cognitive Assessment)More sensitive than MMSE for mild cognitive impairment and executive/frontal dysfunction; commonly used in memory clinics
ACE-III (Addenbrooke's Cognitive Examination)Detailed assessment across five domains (attention, memory, fluency, language, visuospatial), used in specialist memory clinics to help distinguish dementia subtypes

These tools screen for and quantify cognitive impairment; none of them alone makes a diagnosis of dementia, which requires the impairment to be shown to be progressive, to affect function, and to have other causes excluded.

Excluding reversible causes

Before attributing cognitive decline to a primary neurodegenerative dementia, a standard panel excludes reversible or contributory causes, some of which are entirely treatable.

First-line investigations for suspected dementia.
TestWhat it screens for
FBCAnaemia, infection
U&EsRenal impairment, hyponatraemia
LFTsHepatic encephalopathy
TSHHypothyroidism - an important, treatable mimic
CalciumHyper/hypocalcaemia
B12 and folateDeficiency, a treatable cause of cognitive impairment
HbA1c/glucoseDiabetes, hypoglycaemia
Syphilis/HIV serologyIn selected cases with risk factors or atypical presentation
Structural brain imaging (CT or MRI)Excludes normal pressure hydrocephalus, subdural haematoma, tumour, and significant cerebrovascular disease; MRI also helps subtype dementia (e.g. hippocampal atrophy in Alzheimer's)

Mild cognitive impairment

Mild cognitive impairment (MCI) describes objectively demonstrable cognitive decline that is greater than expected for age but does not yet significantly impair day-to-day function - the functional threshold is what separates it from dementia. It is a useful and increasingly recognised category, but it is not a benign reassurance: a proportion of people with MCI progress to dementia each year, while others remain stable and some revert to normal cognition, particularly where a reversible contributor (depression, medication, sleep disorder, thyroid disease) is identified and treated.

  • Identify and correct reversible contributors, since these account for a meaningful share of those who improve
  • Address cardiovascular risk factors, which influence progression particularly where there is a vascular component
  • Encourage physical activity, cognitive and social engagement, and hearing correction, all associated with better cognitive trajectories
  • Arrange planned review to detect functional decline that would indicate progression to dementia, rather than either discharging or over-investigating

Referral to specialist assessment

Suspected dementia, once reversible causes have been reasonably excluded, should be referred to a memory clinic or specialist old age psychiatry/geriatric medicine service for formal diagnosis, subtyping and initiation of any disease-specific treatment. Diagnosis and subtyping (Alzheimer's, vascular, Lewy body, frontotemporal, or mixed) generally requires more detailed neuropsychological assessment and, often, specialist imaging than is available in a single primary care consultation - see the specific subtype articles (3, 4, 5) for the distinguishing features of each.

Diagnosis disclosure

Communicating a dementia diagnosis draws on the same principles as breaking any significant diagnosis (see the SPIKES-based approach discussed under consultation skills), adapted for the specific sensitivities of a progressive cognitive illness.

  • Establish what the patient already knows or suspects, and how much they want to know, before delivering information
  • Address the patient directly, even when a family member is present, preserving autonomy and dignity as far as possible
  • Give information in manageable amounts, checking understanding, since processing complex new information is itself affected by the condition
  • Explore emotional reaction explicitly and allow time for it before moving to practical planning
  • Discuss next steps concretely: post-diagnostic support, safety planning, and what happens now, so the consultation ends with a plan rather than only the diagnosis

Post-diagnostic support

A dementia diagnosis should trigger a structured package of support, not end at the point of disclosure.

  • Named care coordinator (often a dementia support worker or Admiral Nurse) to help navigate services
  • Information and signposting to dementia-specific charities and support groups for both patient and family
  • Planning for the future while capacity allows: Lasting Power of Attorney (for finances and for health/welfare decisions), advance care planning, and discussion of future wishes
  • Driving: a legal duty to notify the DVLA of a dementia diagnosis exists; some people can continue driving depending on severity and type, assessed individually rather than by diagnosis alone
  • Carer assessment and support, recognising the substantial and sustained burden of caring for someone with dementia - see 6 on carer support generally
  • Safety review: driving, cooking, medication management, and home safety, revisited as the condition progresses
  • Regular review of both the patient's condition and the adequacy of support in place, since needs change as dementia progresses

Risk reduction

A substantial proportion of dementia cases worldwide are attributable to potentially modifiable risk factors across the life course, which means dementia risk reduction is a legitimate clinical activity rather than purely a matter of genetic luck. The Lancet Commission on dementia prevention groups these by life stage.

Potentially modifiable dementia risk factors by life stage.
Life stageRisk factors
Early lifeLess education, which reduces cognitive reserve
MidlifeHearing loss, hypertension, obesity, excess alcohol, head injury
Later lifeSmoking, depression, social isolation, physical inactivity, diabetes, air pollution, visual loss

Hearing loss deserves particular emphasis because it is common, easily overlooked and readily treatable - correcting it with hearing aids is associated with better cognitive outcomes, plausibly by maintaining cognitive stimulation and social engagement. Asking about hearing, and checking that existing aids are working and being worn, is a low-cost intervention with a genuine evidence base behind it.

Capacity

A dementia diagnosis does not itself mean a person lacks capacity for any given decision. Capacity is decision-specific and time-specific, assessed under the Mental Capacity Act 2005 framework for the particular decision in question at the particular time it needs to be made - a person may retain capacity for everyday decisions well into the course of dementia while losing capacity earlier for more complex decisions (e.g. managing a large financial transaction). This is covered in detail in the capacity and best interests article; see 7.

Red flags

Prognosis

Most dementias are progressive and, currently, without a disease-modifying cure for the majority of cases, though rate of progression varies considerably between individuals and subtypes. The realistic aim of assessment and diagnosis is to identify any reversible contributing factors, initiate appropriate disease-specific and symptomatic treatment where available, and put in place the support, planning and safeguards that meaningfully improve quality of life and safety for both the person with dementia and their carers over the course of the illness.

An important framing point is that dementia is a life-limiting condition, and recognising it as such - rather than only as a cognitive disorder - allows timely palliative and anticipatory care planning. In advanced disease the priorities shift towards comfort, dignity, symptom control and avoiding burdensome interventions such as repeated hospital admission, and these conversations are far better held early, while the person can still contribute to them, than deferred until a crisis forces a decision by default.

References

  1. Alzheimer's Society. Facts for the media / dementia statistics. Available here
  2. NICE CG103. Delirium: prevention, diagnosis and management. 2010, updated 2023. Available here
  3. NICE NG97. Dementia: assessment, management and support for people living with dementia and their carers. 2018. Available here
  4. NICE NG97 (vascular dementia section). Available here
  5. NICE NG97 (Lewy body/frontotemporal dementia section). Available here
  6. Care Act 2014. Carer's assessment provisions. Available here
  7. Mental Capacity Act 2005 Code of Practice. Available here

This article is written for revision and education. It is not clinical guidance and must not be used to make decisions about the care of a patient. Always check current NICE guidance and local protocols.

← All Geriatric Medicine notes